Comparing Ceres Ventures (OTCMKTS:CEVE) & Fresenius SE & Co. (OTCMKTS:FSNUY)

Ceres Ventures (OTCMKTS:CEVE) and Fresenius SE & Co. (OTCMKTS:FSNUY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Profitability

This table compares Ceres Ventures and Fresenius SE & Co.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ceres Ventures	N/A	N/A	N/A
Fresenius SE & Co.	6.55%	10.29%	4.77%

Valuation and Earnings

This table compares Ceres Ventures and Fresenius SE & Co.”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ceres Ventures	N/A	N/A	N/A	N/A	N/A
Fresenius SE & Co.	$25.87 billion	1.01	$1.43 billion	$0.75	15.47

Fresenius SE & Co. has higher revenue and earnings than Ceres Ventures.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Ceres Ventures and Fresenius SE & Co., as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ceres Ventures	0	0	0	0	0.00
Fresenius SE & Co.	0	0	3	0	3.00

Given Ceres Ventures’ higher possible upside, analysts plainly believe Ceres Ventures is more favorable than Fresenius SE & Co..

Risk & Volatility

Ceres Ventures has a beta of 24.34, meaning that its share price is 2,334% more volatile than the S&P 500. Comparatively, Fresenius SE & Co. has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.

Summary

Fresenius SE & Co. beats Ceres Ventures on 6 of the 8 factors compared between the two stocks.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.

About Fresenius SE & Co.

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.